Large international study finds diabetes drug cuts cardiovascular and kidney problems
A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.
Jun 10, 2019
0
74